Skip to content
GLP-1 Scorecard
Menu

Site position #10

Vitara RX

By GLP-1 ScorecardUpdated
Factor scores not reassessed.

Compounded GLP-1 marketplace with conflicting advertised prices and unresolved shipping-policy details.

Our take

Vitara's low-price pitch needs clarification before it earns a value recommendation. Its site was rebuilt in November with new prices, and most of the policy pages this review relied on no longer load, leaving the charge and the terms for a selected plan unresolved.

Is it for you?Best fit and reasons to look elsewhere
Best for
Cash-pay shoppers who value online access and provider messaging but will resolve the actual treatment offer before ordering.
Look elsewhere if
People who need insurance billing or assured Alaska service. The FAQ says insurance is not accepted and its published state list omits Alaska.
Semaglutide
Advertised from $99/month with an annual plan and discount code ($279 reference); conflicting displays—confirm selected charge.
Tirzepatide
Advertised from $198/month with an annual plan and discount code ($389 reference); conflicting displays—confirm selected charge.
Coverage
Site lists 49 states, Alaska omitted; confirm medication-specific availability
Brand-name
Not confirmed
In this review
Visit Vitara RXWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Weigh Vitara RX against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives before comparing prices. The trial evidence behind the drugs themselves is in our research library, kept separate from these grades. Every listing is graded on the same six factors as this one. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe before you order. Compounded preparations are not FDA-approved, so the pharmacy and prescriber matter.

A new pricing page advertises semaglutide from $99 a month against a $279 reference price and tirzepatide from $198 against $389, with the wording “with an annual plan” and a discount code. On November 2 the homepage showed $99 and $149 on its cards and $179.99 in its headline.

Confirm the selected price

The Ondra and Vitara comparison puts a published monthly option beside the Vitara charge you still need to confirm. If ClickSlim is also on your shortlist, use the ClickSlim comparison to ask both providers for the first charge and the refill terms.

Vitara rebuilt its site in November. On November 12 the FAQ, terms, returns policy, about page and HIPAA notice cited here returned not-found and no replacements were linked; only a privacy policy loaded. The statements below that rely on those pages are as read on November 2, and the current terms need to be requested. The November 2 terms warned that website information can be inaccurate or outdated and that a referenced price may be corrected. A written treatment offer should therefore identify the prescribed medication, amount supplied, payment period and final charge together. Treating the lowest visible number as a completed quote would skip the central uncertainty here. Our six-month cost guide helps compare quotes over the same period.

The SnagRx comparison separates a one-month quote from an annual monthly equivalent before comparing what you would pay.

Resolve the storage mismatch

The homepage says to refrigerate GLP-1 medication; the returns policy says no refrigerated products are shipped. This mismatch leaves appropriate delivery conditions unresolved.

For a lost parcel, the returns page describes working with the carrier and reshipping. That remedy does not resolve the storage mismatch.

If the price or terms here do not fit, our Sprout Health review and our GoodLife Health review set out the prices, renewal terms and what we could not verify for each. Both sellers pay us a commission when a reader signs up, which never changes a grade.

Separate the storefront from the people delivering care

Vitara's terms say clinical treatment and prescriptions are not guaranteed; the provider decides what is appropriate. They also allow a prescription to be directed to a pharmacy of your choosing. A payment or a pharmacy name on a website is therefore insufficient to establish the actual prescription and dispensing arrangement.

The FAQ names MD Integrations as its provider network and Manifest Pharmacy as a possible dispenser. Those disclosures don't establish your assigned clinician or dispensing branch. Our pharmacy verification guide covers checks against that specific facility.

The HIPAA notice speaks in the voice of a pharmacy, while the website footer describes a marketplace that does not directly dispense. This difference leaves the responsible entity unclear. It does not establish that Vitara owns a pharmacy or prove any pharmacy's physical identity.

The separate privacy policy largely describes pharmacy-price comparisons and discount cards. That scope does not clearly explain the data flow for the advertised GLP-1 care. The patient needs the notices for the actual treating and dispensing entities, not an assumption that one website policy answers every privacy question.

Use the actual state list

Vitara publishes 49 states in its FAQ, with Alaska absent. That is a statement about its listed service area, not an independent check of clinician or pharmacy licenses. Even within a listed state, the actual prescription and dispensing arrangement still need to fit the patient.

Stopping shipments and returning prescriptions are different

The FAQ says medication is billed when shipped, with contact before refilling, and allows account cancellation. It does not specify one renewal notice period or subscription schedule. This is insufficient to assume one-time billing.

The returns policy allows subscription cancellation before products ship, then makes sales final after payment and carrier handoff. Its possible thirty-day returns concern unopened nonprescription goods, not these prescriptions. Our cancellation guide helps distinguish stopping another shipment from returning an order already sent.

Care access is useful; its scope still matters

Vitara's about page offers ongoing provider messaging and identifies compounded products as not FDA-approved. It does not set out a universal lab panel, testing price or follow-up schedule. A useful care plan needs those practical details alongside the final charge, rather than leaving ongoing support as an open-ended promise.

Compare Vitara RX

More comparisons (1)

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value93/100
Dose & formulation80/100
Clinical oversight85/100
Labs & monitoring83/100
Fulfillment87/100
Contract terms86/100

Strengths

  • Named compounded semaglutide and tirzepatide offerings
  • Ongoing provider messaging advertised
  • Terms allow directing prescriptions to another pharmacy

What to consider

  • Prices changed with a November site rebuild; annual-plan and discount-code conditions need confirming
  • FAQ, terms and returns pages cited earlier no longer load
  • Published list omitted Alaska
  • Refrigeration instructions conflict with the returns policy
  • No universal lab schedule or testing price established
  • Website policy descriptions leave clinical and dispensing roles unclear

Bottom line — Grade B

Factor scores not reassessed.

Site position #10 of 515. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Vitara RX — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Prices and terms can change; confirm them with Vitara RX. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard